IP Library Granted Patent US 10,363,439
Granted Patent B2
US 10,363,439 · App. 14/464,148 · Granted Jul 30, 2019

Ion acceleration complex for the treatment of atrial fibrillations

Inventor: Ugo Amaldi (Geneva, CH)
Assignee: FONDAZIONE PER ADROTERAPIA ONCOLOGICA—TERA
A61N5/1064A61N5/1067H05H7/22H05H9/041A61N2005/1087H05H2277/11
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,363,439
App. No.
14/464,148
Granted
Jul 30, 2019
Kind
B2
Abstract

A system ( 12 ) is proposed for the acceleration of ions to treat Atrial Fibrillation (AF), arteriovenous malformations (AVMS) and focal epileptic lesions; this system ( 12 ) includes a pulsed ion source ( 1 ), a pre-accelerator ( 3 ) and one or more linear accelerators or linacs ( 5, 6, 7 ) operating at frequencies above 1 GHz with a repetition rate between 1 Hz and 500 Hz. The particle beam coming out of the complex ( 12 ) can vary (i) in intensity, (ii) in deposition depth and (iii) transversally with respect to the central beam direction. The possibility of adjusting in a few milliseconds and in three orthogonal directions, the location of each energy deposition in the body of the patient makes that system of accelerators ( 12 ) perfectly suited to irradiation of a beating heart.

Claims (120)

1. An accelerator complex ( 12 ) comprising:

an ion source ( 1 ) configured for producing beam pulses of ions with an atomic number between 1 (protons) and 10 (neon ions),

a pre-accelerator ( 3 ) configured for accelerating rates of the beam pulses,

a high-energy section ( 13 ) configured to receive beam pulses from the pre-accelerator ( 3 ), the high-energy section ( 13 ) containing at least one linac ( 5 ; 6 ; 7 ) comprising a plurality of units and configured to:

(i) run at a frequency larger than 1 GHz with a repetition rate between 10 Hz and 400 Hz, and

(ii) vary energy of outgoing accelerated ions by acting on the radiofrequency sources of at least one linac ( 7 ) to switch off a number of units, and to vary the power and the phase of the radiofrequency power pulses sent to the final active units of a last section of the linac,

said outgoing accelerated ions of beam pulses forming a spot that deliver a dose of beam pulses to a target area of a patient's body,

a three-dimensional feedback system configured to vary, before sending every spot, two transverse positions and a depth in the patient's body so as to compensate for the movements of a targeted area such that the dose of beam pulses delivered by every spot is limited to a targeted area in order to reduce unwanted irradiation to non-targeted areas, and

a High Energy Beam Transport channel (HEBT) with an associated magnet system that transports the beam pulses forming every spot from the high-energy section ( 13 ) to a treatment room of said patient,

wherein the configuration of the units and the configuration of the three-dimensional feedback system is such that the variation of the depth by the three-dimensional feedback system corresponds to the variation of energy of outgoing accelerated ions.

2. The complex for ion acceleration ( 12 ) according to claim 1 , wherein the high-energy section ( 13 ) contains two or three linac section(s) and one or more linac sections ( 5 ; 6 ; 7 ) run at different frequencies.

3. The complex for ion acceleration ( 12 ) according to claim 1 , wherein the complex comprises more than one pre-accelerator ( 3 ) configured for accelerating rates of the beam pulses.

4. The complex for ion acceleration ( 12 ) according to claim 1 , wherein the pre-accelerator ( 3 ) is a room temperature, a superconducting Linac, or a Radio Frequency Quadrupole (RFQ).

5. The complex for ion acceleration ( 12 ) according to claim 1 , wherein the pre-accelerator ( 3 ) is a room temperature, a superconducting cyclotron/synchrocyclotron, or a FFAG accelerator.

6. The complex for ion acceleration ( 12 ) according to claim 1 , wherein the ion source ( 1 ) is computer controlled so as to adjust the dose delivered in every single spot.

7. The complex for ion acceleration ( 12 ) according to claim 1 , wherein the complex comprises an associated layout ( 14 ) of pulse beam transport to rooms, robotic chairs, or beds other locations ( 11 a , 11 b , 11 c ) for treatment of patients in a computer controlled manner, the associated layout ( 14 ) includes a magnet fan-out ( 9 ) with associated intermediate beam transport lines ( 10 a , 10 b , 10 c ), each intermediate beam transport line having two magnets configured for transverse scanning and a monitoring system.

8. The complex for ion acceleration ( 12 ) according to claim 1 , wherein the linac ( 5 ; 6 ; 7 ) is a 3 GHz linac that is configured to accelerate 4He2+ ions and is configured to operate with the following parameters:

Frequency [MHz]

2998

Q (ion charge)

2

A (ion mass number)

4

Input energy [MeV/u]

60

Total input energy [MeV]

240

Maximum output energy [MeV/u]

160

Maximum total output energy [MeV]

640

Number of cells in an accelerating structure

18-16

(or tank)

Iris diameter [mm]

7

Number of units

10

Unit length [m]

0.75-1.05

Total length of the linac [m]

9.5

Average transit time factor T

0.85

Effective Shunt Impedance's = ZT2 [MΩ/m]

53-77

Average electric field on the axis E0 [MV/m]

33

Maximum surface electric field [MV/m]

140

Transverse normalized acceptance at 2 rms

2.4

[π mm mrad]

Peak power per unit [MW]

10

RF Pulse duration [μs]

4

Repetition rate [Hz]

120

Fraction of time with beam (or duty cycle) [%]

0.048

Average power to feed the 10 klystrons [kW]

150.

9. A method for the treatment of atrial fibrillation by spot scanning and multi-painting technique, comprising administering to a patient in need thereof accelerated ions from an accelerator complex according to claim 1 , wherein a three-dimensional feedback system is foreseen to treat the patient without unwanted irradiation of the tissues that need to be spared.

10. A method for the treatment of arteriovenous malformations (AVMs) and focal epileptic lesions, comprising administering to a patient in need thereof accelerated ions from an accelerator complex according to claim 1 , wherein a three-dimensional feedback system is foreseen to treat the patient without unwanted irradiation of the tissues that need to be spared.

11. An accelerator complex ( 12 ) comprising:

an ion source ( 1 ) configured for producing beam pulses of ions with an atomic number between 1 (protons) and 10 (neon ions),

a pre-accelerator ( 3 ) configured for accelerating rates of the beam pulses,

a high-energy section ( 13 ) configured to receive beam pulses from the pre-accelerator ( 3 ), the high-energy section ( 13 ) containing at least one 3 GHz linac ( 5 ; 6 ; 7 ) that is configured to accelerate 4He2+ ions of beam pulses produced by said ion source ( 1 ) and to operate with the following parameters:

Frequency [MHz]

2998

Q (ion charge)

2

A (ion mass number)

4

Input energy [MeV/u]

60

Total input energy [MeV]

240

Maximum output energy [MeV/u]

160

Maximum total output energy [MeV]

640

Number of cells in an accelerating

18-16

structure (or tank)

Iris diameter [mm]

7

Number of units

10

Unit length [m]

0.75-1.05

Total length of the linac [m]

9.5

Average transit time factor T

0.85

Effective Shunt Impedance's = ZT2

53-77

[MΩ/m]

Average electric field on axis E0 [MV/m]

33

Maximum surface electric field [MV/m]

140

Transverse normalized acceptance at 2 rms

2.4

[π mm mrad]

Peak power per unit [MW]

10

RF Pulse duration [μs]

4

Repetition rate [Hz]

120

Fraction of time with beam (or duty cycle)

0.048

[%]

Average power to feed the 10 klystron [kW],

150

 the high-energy section ( 13 ) being configured to vary energy of outgoing accelerated 4He2+ ions by acting on the radio frequencies sources of at least one linac ( 7 ), said outgoing accelerated 4He2+ ions of beam pulses forming a spot that delivers a dose of beam pulses to a target area of a patient's body,

a three-dimensional feedback system configured to vary, before sending every spot, two transverse positions and a depth in the patient's body so as to compensate for the movements of a targeted area such that the dose of beam pulses delivered by every spot is limited to a targeted area in order to reduce unwanted irradiation to non-targeted areas, and

a High Energy Beam Transport channel (HEBT) with an associated magnet system that transports the beam pulses forming every spot from the high-energy section ( 13 ) to a treatment room of said patient.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2022
From: FONDAZIONE PER ADROTERAPIA ONCOLOGICA - TERA
To: ADVANCED ONCOTHERAPY PLC
Reel/Frame 058545/0650 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2014
From: AMALDI, UGO
To: FONDAZIONE PER ADROTERAPIA ONCOLOGICA - TERA
Reel/Frame 034434/0001 →
Priority Claims (1)
IT CO2013A0036 · Aug 22, 2013 · national
Continuity (1)
Related Publication 20150057484A1 · Feb 26, 2015
Cited By (3)
US 12,311,200 US 12,318,632 US 12,558,570